Literature DB >> 25053712

AGE metabolites: a biomarker linked to cancer disparity?

Dion Foster1, Laura Spruill1, Katherine R Walter1, Lourdes M Nogueira1, Hleb Fedarovich1, Ryan Y Turner1, Mahtabuddin Ahmed2, Judith D Salley2, Marvella E Ford3, Victoria J Findlay4, David P Turner5.   

Abstract

Socioeconomic and environmental influences are established factors promoting cancer disparity, but the contribution of biologic factors is not clear. We report a mechanistic link between carbohydrate-derived metabolites and cancer that may provide a biologic consequence of established factors of cancer disparity. Glycation is the nonenzymatic glycosylation of carbohydrates to macromolecules, which produces reactive metabolites called advanced glycation end products (AGE). A sedentary lifestyle and poor diet all promote disease and the AGE accumulation pool in our bodies and also increase cancer risk. We examined AGE metabolites in clinical specimens of African American and European American patients with prostate cancer and found a higher AGE concentration in these specimens among African American patients when compared with European American patients. Elevated AGE levels corresponded with expression of the receptor for AGE (RAGE or AGER). We show that AGE-mediated increases in cancer-associated processes are dependent upon RAGE. Aberrant AGE accumulation may represent a metabolic susceptibility difference that contributes to cancer disparity. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25053712      PMCID: PMC4184970          DOI: 10.1158/1055-9965.EPI-14-0564

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

Review 1.  [Non-enzymatic glycation of proteins: from diabetes to cancer].

Authors:  N A Ansari; Z Rasheed
Journal:  Biomed Khim       Date:  2010 Mar-Apr

2.  Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth.

Authors:  Indira Elangovan; Sivasakthivel Thirugnanam; Aoshuang Chen; Guoxing Zheng; Maarten C Bosland; André Kajdacsy-Balla; Munirathinam Gnanasekar
Journal:  Biochem Biophys Res Commun       Date:  2011-12-20       Impact factor: 3.575

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

4.  Advanced glycation end products in foods and a practical guide to their reduction in the diet.

Authors:  Jaime Uribarri; Sandra Woodruff; Susan Goodman; Weijing Cai; Xue Chen; Renata Pyzik; Angie Yong; Gary E Striker; Helen Vlassara
Journal:  J Am Diet Assoc       Date:  2010-06

5.  Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.

Authors:  Peter Boor; Peter Celec; Michal Behuliak; Peter Grancic; Anton Kebis; Marián Kukan; Nadezda Pronayová; Tibor Liptaj; Tammo Ostendorf; Katarína Sebeková
Journal:  Metabolism       Date:  2009-07-15       Impact factor: 8.694

6.  Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Howard L Parnes; Ashraful Hoque; Scott M Lippman; Siobhan Sutcliffe; Sarah B Peskoe; Charles G Drake; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-18       Impact factor: 4.254

Review 7.  Minireview: the molecular and genomic basis for prostate cancer health disparities.

Authors:  Isaac J Powell; Aliccia Bollig-Fischer
Journal:  Mol Endocrinol       Date:  2013-04-22

8.  Determination of N epsilon-(carboxymethyl)lysine in foods and related systems.

Authors:  Jennifer M Ames
Journal:  Ann N Y Acad Sci       Date:  2008-04       Impact factor: 5.691

9.  Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.

Authors:  Beatriz Duran-Jimenez; Darin Dobler; Sarah Moffatt; Naila Rabbani; Charles H Streuli; Paul J Thornalley; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

10.  Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study.

Authors:  Deepak Agrawal; Melissa B Davis; Sean Yoder; Folakemi T Odedina; Nagi Kumar; Joseph M Higginbotham; Titilola Akinremi; Sandra Suther; Karam Fa Soliman; R Renee Reams
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

View more
  19 in total

1.  Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.

Authors:  Tina E Brinkley; Xiaoyan Leng; Barbara J Nicklas; Stephen B Kritchevsky; Jingzhong Ding; Dalane W Kitzman; W Gregory Hundley
Journal:  Metabolism       Date:  2017-02-10       Impact factor: 8.694

2.  Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Authors:  Tino W Sanchez; Guangyu Zhang; Jitian Li; Liping Dai; Saied Mirshahidi; Nathan R Wall; Clayton Yates; Colwick Wilson; Susanne Montgomery; Jian-Ying Zhang; Carlos A Casiano
Journal:  Mol Cell Proteomics       Date:  2016-10-14       Impact factor: 5.911

3.  Oxidative Stress-Related Molecular Biomarker Candidates for Glaucoma.

Authors:  Gözde Hondur; Emre Göktas; Xiangjun Yang; Lama Al-Aswad; James D Auran; Dana M Blumberg; George A Cioffi; Jeffrey M Liebmann; Leejee H Suh; Danielle Trief; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

Review 4.  Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.

Authors:  David P Turner
Journal:  Cancer Res       Date:  2015-04-28       Impact factor: 12.701

5.  Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.

Authors:  Morgan L Zenner; Yves B Helou; Ryan J Deaton; Maria Sverdlov; Heng Wang; Andre Kajdacsy-Balla; Virgilia Macias; Cindy Voisine; Marcus Murray; Sarki A Abdulkadir; Adam B Murphy; Larisa Nonn
Journal:  Prostate       Date:  2021-12-02       Impact factor: 4.104

6.  Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Lindsay L Peterson; Seho Park; Yikyung Park; Graham A Colditz; Narges Anbardar; David P Turner
Journal:  Cancer       Date:  2020-02-25       Impact factor: 6.860

Review 7.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 8.  The Role of Advanced Glycation End-Products in Cancer Disparity.

Authors:  D P Turner
Journal:  Adv Cancer Res       Date:  2016-10-12       Impact factor: 5.767

9.  Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Authors:  Katherine R Walter; Marvella E Ford; Mathew J Gregoski; Rita M Kramer; Kendrea D Knight; Laura Spruill; Lourdes M Nogueira; Bradley A Krisanits; Van Phan; Amanda C La Rue; Michael B Lilly; Stefan Ambs; King Chan; Tonya F Turner; Heidi Varner; Shweta Singh; Jaime Uribarri; Elizabeth Garrett-Mayer; Kent E Armeson; Ebony J Hilton; Mark J Clair; Marian H Taylor; Andrea M Abbott; Victoria J Findlay; Lindsay L Peterson; Gayenell Magwood; David P Turner
Journal:  Breast Cancer Res Treat       Date:  2018-10-27       Impact factor: 4.624

Review 10.  Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management.

Authors:  Sotiria Palimeri; Eleni Palioura; Evanthia Diamanti-Kandarakis
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-01       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.